Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
Jung Im Shin
Bloomberg School of Public Health
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Canagliflozin
18%
Cardiovascular Diseases
17%
Chronic Renal Insufficiency
10%
Delivery of Health Care
7%
Dipeptidyl-Peptidase IV Inhibitors
46%
empagliflozin
18%
Endocrinologists
15%
Endocrinology
13%
Glucagon-Like Peptide-1 Receptor
75%
Glucose
81%
Guidelines
30%
Heart Failure
8%
Liraglutide
16%
Metformin
12%
National Institutes of Health (U.S.)
12%
Pharmaceutical Preparations
9%
Pharmacology
7%
Physicians
7%
Randomized Controlled Trials
7%
rGLP-1 protein
21%
Risk Assessment
9%
Sodium-Glucose Transport Proteins
100%
Therapeutics
21%
Thiazolidinediones
15%
Type 2 Diabetes Mellitus
97%
Uncertainty
10%